RR No. 1-2021 exempts qualified COVID-19 vaccine procurement, importation, donation and services from VAT, excise tax, donor’s tax and fees beginning January 1, 2021.
Businesses, local government units, private entities, and humanitarian organizations involved in COVID-19 vaccine procurement or donation must treat qualified vaccine transactions as tax-exempt beginning January 1, 2021, but only if the vaccines are not for resale or commercial use and are distributed without consideration under the National Governmentâs COVID-19 Vaccination Program. RR No. 1-2021 implements Section 11 of Republic Act No. 11525, or the COVID-19 Vaccination Program Act of 2021, by removing VAT, excise tax, donorâs tax, customs duties, and other fees from qualified vaccine-related transactions.
What RR No. 1-2021 Changed
RR No. 1-2021 provides the tax rules for the procurement, importation, donation, storage, transport, deployment, and administration of COVID-19 vaccines under the governmentâs vaccination program. The key rule is straightforward: beginning January 1, 2021, qualified transactions involving COVID-19 vaccines are exempt from value-added tax, excise tax, donorâs tax, customs duties, and other fees.
The exemption covers transactions made by the National Government, through the Department of Health and the National Task Force Against COVID-19, political subdivisions of the State, and private entities or international humanitarian organizations such as the Philippine Red Cross. This is important for companies and organizations participating in vaccine procurement because the tax treatment directly affects contract price, import costs, donation documentation, and refund claims for taxes already paid.
The regulation makes clear that the vaccine must not be intended for resale or other commercial use. It must be distributed without consideration to persons to be vaccinated. For private entities, the vaccines must be for the sole and exclusive use of the entity and its related parties, if any, consistent with the rules on COVID-19 vaccine procurement under the government program.
Who Is Affected
RR No. 1-2021 affects several groups. First, it affects government agencies and local government units procuring or receiving COVID-19 vaccines. Second, it affects private companies that entered into vaccine procurement arrangements for employees, related parties, or other qualified beneficiaries. Third, it affects international humanitarian organizations and entities donating COVID-19 vaccines. Fourth, it affects importers, logistics providers, storage providers, transport providers, and service providers involved in the deployment and administration of COVID-19 vaccines.
For corporate accountants, CFOs, and tax managers, the regulation is especially relevant to VAT treatment on vaccine purchase contracts, VAT and excise tax on importation, donorâs tax on vaccine donations, and input VAT reporting. The searched business phrases for this issuance include RR No. 1-2021 COVID-19 vaccine tax exemption, VAT exemption vaccine procurement Philippines, donorâs tax exemption COVID-19 vaccine donation, COVID-19 vaccine importation tax exemption, and BIR rules on vaccine logistics VAT.
Tax Exemptions and Fee Privileges
No VAT shall be imposed on the procurement of COVID-19 vaccines by the entities covered by RR No. 1-2021. Because of this, VAT should not form part of the contract price for the procurement of COVID-19 vaccines by qualified entities.
No VAT and excise tax shall be imposed on the importation of COVID-19 vaccines by the covered entities. This is a material rule for import planning because it directly affects landed cost, customs processing assumptions, and tax accounting for imported vaccine shipments.
The importation of COVID-19 vaccines allowed under RR No. 1-2021 shall not be subject to the issuance of an Authority to Release Imported Goods under Revenue Memorandum Order No. 35-2002, as amended. The vaccines may be released by the Bureau of Customs without the need for an ATRIG. However, the BIR may conduct a post-investigation or post-audit on importations released by the Bureau of Customs without ATRIG pursuant to the regulation.
No VAT shall be imposed on services rendered to the covered entities for the storage, transport, deployment, and administration of COVID-19 vaccines. VAT should therefore not form part of the contract price for qualified storage, transport, deployment, and administration services.
No donorâs tax shall be imposed on the donation of COVID-19 vaccines to the covered entities, subject to the ordinary rules on deductibility under Section 34(H) of the National Internal Revenue Code of 1997, as amended, and existing rules and regulations, if applicable.
Requirements to Claim the Exemption
Covered entities availing of the exemption from VAT, excise tax, and donorâs tax must present specific documents. The first requirement is a certified true copy of the COVID-19 vaccine procurement agreement or multiparty agreement, as applicable. For local government units and private entities, the multiparty agreement must include the Department of Health and the relevant supplier of the COVID-19 vaccine.
The second requirement is a certified true copy of the COVID-19 vaccineâs Certificate of Product Registration or Emergency Use Authorization issued by the Food and Drug Administration. This is significant because the tax exemption is tied to qualified vaccines covered by the regulatory framework for the COVID-19 vaccination program.
The third requirement is a sworn declaration from the taxpayer-buyer, importer, or donee stating that the COVID-19 vaccines are not intended for resale or commercial use and will be distributed without consideration to persons to be vaccinated in accordance with the National Governmentâs COVID-19 Vaccination Program. For private entities, the sworn declaration must also state that the vaccines are for the sole and exclusive use of such entities and their related parties, if any, as discussed under Section 4 of RR No. 19-2020.
For COVID-19 vaccines donated to covered entities, additional documents are required. If the donation is made to the National Government or local government units, a certified true copy of the duly accepted Deed of Donation must be presented. If the donation is made to private entities or international humanitarian organizations, a certified true copy of the duly accepted Deed of Donation and/or BIR Form 2322, or Certificate of Donation, must be provided.
Transitory Rules and Refunds for Taxes Already Paid
RR No. 1-2021 contains an important transitory provision for transactions made before the regulation took effect but after the statutory effective date. The grant of exemption for importation of COVID-19 vaccines, procurement of storage, transport, deployment, and administration services, and donation of COVID-19 vaccines is deemed in effect beginning January 1, 2021.
Any VAT that may have been paid on qualified shipments, importations, or services from January 1, 2021 until the effectivity of the regulations shall be refunded under Section 204(C) of the Tax Code, in accordance with existing refund rules and procedures. However, the input VAT on imported items or services must not have been reported and claimed as input tax credit in the monthly and/or quarterly VAT returns.
The same amount shall not be allowed as input tax credit under Section 110 of the Tax Code for purposes of computing the VAT payable of the concerned taxpayer for the relevant period. Similarly, excise tax and donorâs tax on covered and qualified transactions paid from January 1, 2021 until the effectivity of the regulations shall be refunded pursuant to Section 204(C) of the Tax Code and its implementing rules.
Effective Date and Duration
RR No. 1-2021 took effect beginning January 1, 2021. It remains in full force and effect during the period of the state of calamity under Proclamation No. 1021 dated September 16, 2020 issued by the President of the Philippines.
The regulation was signed with the recommendation of the Commissioner of Internal Revenue and approval of the Secretary of Finance. Businesses and covered entities should therefore treat the January 1, 2021 date as critical for determining whether a qualified transaction may be exempt or whether a refund may be pursued for taxes paid during the transition period.
Penalties and Risks for Non-Compliance
RR No. 1-2021 does not impose a separate special penalty provision. However, non-compliance creates practical tax risks. A taxpayer that cannot present the required procurement agreement, FDA authorization, sworn declaration, deed of donation, or BIR Form 2322 may lose the benefit of the exemption. A taxpayer that claims both a refund and input VAT credit for the same amount risks disallowance because the regulation expressly prohibits allowing the same amount as input tax credit when it is subject to refund treatment.
There is also a post-audit risk. While the importation of qualified COVID-19 vaccines may be released by the Bureau of Customs without ATRIG, the BIR may conduct a post-investigation or post-audit on such importations. Importers and companies should therefore maintain complete records showing that the vaccines were qualified, covered by the program, not intended for resale, and distributed without consideration.
Practical Steps for Businesses, LGUs, and Humanitarian Organizations
Covered entities should first confirm whether their transaction falls within the procurement, importation, donation, storage, transport, deployment, or administration of COVID-19 vaccines under the National Governmentâs vaccination program. They should then verify whether the counterparty and transaction structure fall within RR No. 1-2021, especially if the procurement involved a local government unit or private entity under a multiparty agreement.
Second, businesses should review contract pricing. Qualified vaccine procurement contracts and qualified service contracts should not include VAT as part of the price. If VAT was paid from January 1, 2021 until the effectivity of RR No. 1-2021, the taxpayer should determine whether a refund under Section 204(C) is available and confirm that the same amount was not claimed as input VAT credit.
Third, taxpayers should compile documentary proof before claiming the exemption. At minimum, they should keep certified true copies of the procurement agreement or multiparty agreement, FDA Certificate of Product Registration or Emergency Use Authorization, sworn declaration of non-resale and free distribution, and donation documents where applicable.
Fourth, importers should maintain import records even when no ATRIG was required. The exemption from ATRIG does not remove the possibility of BIR post-audit. The documentation file should be ready before any BIR verification, especially where large shipments or multiple vaccine-related service contracts are involved.
How Ablola, Saribong & Gueco Can Help
RR No. 1-2021 is more than a historical pandemic-era tax issuance. It shows how the BIR expects taxpayers to document statutory exemptions, prevent double benefit from refunds and input VAT claims, and support import transactions even when ATRIG is not required. Companies that procured, imported, donated, stored, transported, deployed, or administered COVID-19 vaccines should review whether their tax treatment and records are complete.
Ablola, Saribong & Gueco assists businesses, local government suppliers, importers, humanitarian organizations, and corporate taxpayers in BIR compliance, VAT review, tax refund documentation, donorâs tax issues, and regulatory risk assessment. For guidance on RR No. 1-2021, vaccine-related tax exemptions, or BIR compliance in the Philippines, contact Ablola, Saribong & Gueco through MakatiLawFirm.com.